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ABSTRACT
Objective: Cancer is a group of disease characterized by uncontrolled growth of cells. The objective of the study includes the in silico designing of 
benzoxazole bearing azetidinone derivatives as Vascular Endothelial Growth Factor 2 in cancer.
Methods: In silico design of proposed derivatives was conducted using tools such as AutoDock Vina, ACD Lab ChemSketch ver. 12.0, Prediction 
of Activity Spectra for Substances online, molinspiration, and Swiss ADME. The derivatives obeying Lipinski’s Rule of Five in accordance with 
molinspiration were selected for docking studies.
Results: The data obtained from molinspiration revealed that the designed derivatives have physical and chemical properties meant for an orally 
bioavailable drug. From the docking studies derivatives BT1 and BT5 showed high docking score which indicate that these derivatives possess high 
affinity and high polar interaction towards protein 4DBN.
Conclusion: The designed benzoxazole bearing azetidinone derivatives were found to possess good binding affinity and good interaction in the 
binding pocket of the target 4DBN. Therefore, these derivatives are expected to exhibit good anticancer property with minimal side effects.
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INTRODUCTION
Cancer is a disease caused by an uncontrolled growth of abnormal 
cells. It is the second leading cause of death globally. The major types of 
cancers are sarcoma, melanoma, leukemia, lymphoma, and carcinomas. 
Tumor cells do not have any programming so that they do not provide 
any physiological function [1-3].
Benzoxazole and its derivatives constitute an important class of 
heterocycles in drug discovery. These derivatives show anti-bacterial, 
anti-fungal, anti-histaminic, and anti-cancer properties [4-6]. 
Azetidinones are the important scaffold with anti-tubercular, anti-HIV, 
anti-inflammatory activity etc. [7].
Vascular endothelial growth factor (VEGF) signaling pathway creates a 
vital role in governing tumor angiogenesis. Inhibition of the signaling 
pathway is considered as an effective therapeutic target for tumor 
angiogenesis inhibition and successive tumor growth. VEGF receptor 
(VEGFR) is a well-known target for many antineoplastic drugs including 
Sorafenib and Axitinib [8,9].
METHODS
ACD Lab ChemSketch ver. 12.0
ACD Lab ChemSketch ver. 12.0 is a software program helpful in 
the drawing and naming of chemical structures of various organic 
compounds. It gives information about characteristics such as 
calculation of molecular descriptors which include molecular weight, 
Molar volume, surface tension, Parachor, Polarizability, and Refractive 
index.
Molinspiration
It is a free web tool for the calculation of different molecular properties 
needed in QSAR, which includes log P, number of rotatable bonds, 
number of hydrogen bond acceptors, number of hydrogen bond donors, 
and number of violations. The oral bioavailability of synthesized 
derivatives can be predicted by these molecular descriptors which 
come under Lipinski Rule of Five. Molinspiration also help to predict 
the bioactivity score for the most important drug targets.
Prediction of activity spectra for substances (PASS) online
It is an online software for the prediction of biological activities. The 
results can be obtained with a list of over 4000 kinds of pharmacological 
activities consisting of Pa and Pi values arranged in their descending 
order of differences.
● If Pa>0.7, the substance is very likely to exhibit activity and chance 
of being an analog of a known pharmaceutical agent
● If 0.5<Pa>0.7, the substance is likely to exhibit activity and substance 
is unlike known pharmaceutical agent
● If Pa<0.5, substance unlikely to exhibit activity and a chance of being 
a new chemical entity.
Swiss ADME
Swiss ADME is a web tool with free access to the physicochemical, 
pharmacokinetic, and similar properties of powerful molecules. It 
produce predictive models using various methods such as BOILED-Egg 
(Fig. 1), log P, and bioavailability Radar (Fig. 2). In BOILED-Egg model, 
the white region denotes high probability of passive absorption by the 
gastrointestinal tract and yolk region is for high probability of brain 
penetration. In bioavailability radar, the pink area represents the optimal 
range for each property (Lipophilicity: XLOGP3 between –0.7 and +5.0, 
size: Mol Wt. between 150 and 500 g/mol, polarity: TPSA between 20 
and 130 Ao, solubility: log S not higher than 6 etc. The parameters are 
tabulated in Table 1.
Protein data bank
Protein data bank is a resource for various proteins and 
macromolecules. Each entry in PDB is represented by a PBD ID, which 
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visualization whereas PyRx provide a better platform for docking of 
ligand with receptor [10].
Protein preparation
Protein preparation can be done by using Pymol where the protein is 
obtained from Protein Data Bank. This protein structure can be cleaned 
by various commands like remove < >resn < > HOH (for removing 
water) remove < >resn < >DSN (for detergents), remove < > resn < > 
IRE and also small molecules to be eliminated. Finally hydrogen atom 
should be added to the protein structure.
Ligand preparation
The 2D chemical structure of ligands was drawn using ACD Lab 
Chemsketch ver. 12.0 and generated smiles notation. This smiles 
notation is being converted into 3D PDB format with the help of freely 
accessible Corina Online Software.
Docking by autodock vina
Docking was performed using PyRx software program. Selected 
derivatives were loaded into navigation platform. The cleaned 
protein was converted into macromolecules. The docking procedure 
was done by clicking Vina wizard start button and adjusting the 
grid size. The docking scores were obtained which are shown in the 
Table 2.
Table 2: Molecular descriptors of derivatives derived using ACD Lab Chemsketch V 12.0










BT 1 756.1 256.4 40.03 100.98 75.6 1.717
BT 2 793.3 267.2 41.94 105.80 77.6 1.722
BT 3 771.3 253.2 40.63 102.51 86.0 1.743
BT 4 794.4 272.1 41.86 105.51 72.6 1.703
BT 5 813.2 267.4 42.42 107.01 85.4 1.732
Table 1: Pharmacokinetic study by Swiss ADME of derived derivatives
Compound code Formula GI absorption BBB penetration P-gp substrate Pains
BT1 C18H14ClN3O3S Yes No No 0 alert
BT2 C18H13Cl2N3O3S Yes No No 0 alert
BT3 C18H14ClN3O4S Yes No No 0 alert
BT4 C19H16ClN3O3S Yes No No 0 alert
BT5 C18H13ClN4O5S Yes No No 0 alert
Standard C20H16ClFN4O3 Yes No No 0 alert
is a four-character unique identifier called PDB ID, for example, 4DBN. 
Fig. 3 (Crystal Structure of the Kinase domain of Human B-raf with 
a [1,3] thiazolo [5,4-b] pyridine derivative).
Molecular docking
Molecular docking studies are the computational techniques used to 
determine the interaction of two molecules and to find out the best 
orientation of ligand which would form a complex with the intended 
receptor. PyRx and PyMol are the two programs which are used for this 
purpose. PyMol is generally adopted for protein preparation and their 
Fig. 3: Structure of vascular endothelial growth factor receptor 2 
(PDB ID- 4DBN)
Fig. 2: Bioavailability radar diagram of BT1
Fig. 1: Boiled egg model of BT1
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Visualization and analysis
The hydrogen bond, hydrophobic bond, and pi-pi interactions were 
analyzed using PyMol molecular graphic system. PyMOL can be used 
to develop a well-defined 3D image of small molecules, biological 
macromolecules such as proteins [11].
RESULTS
Molecular descriptors
The evaluation of molecular descriptors was done using ACD Lab 
Chemsketch ver. 12.0 is shown in Table 2.
Molinspiration
Molinspiration analysis is used to calculate the physicochemical 
parameters and to analyze Lipinski’s Rule of Five. The results are shown 
in Table 3.
PASS online software
In this study, PASS online was performed. The derivatives showed good 
anti-cancer properties which is tabulated in Table 4.
Prediction of ADME properties
Pharmacokinetic properties evaluated through Swiss ADME, the data 
were obtained are tabulated in Table 1.
Molecular docking
The docking analysis was performed through PyMol and PyRx software 
programs and the results are shown in Table 5 and the figures are 
shown in Fig. 4.
Table 4: Prediction of biological activity of derivatives by PASS
Compound code Activity Pa Pi
BT 1 Anti-cancer 0.829 0.009
BT 2 Anti-cancer 0.780 0.014
BT 3 Anti-cancer 0.811 0.010
BT 4 Anti-cancer 0.797 0.012
BT 5 Anti-cancer 0.788 0.013
PASS: Prediction of Activity Spectra for Substances
Table 5: Docking score of derivatives and standard (sorafenib) 
with protein 4DBN (ligand binding domain of vascular 
endothelial growth factor 2)






6. Standard (Sorafenib) –10.1
Table 3: Lipinski’s Rule analysis of proposed benzoxazole substituted azetidinone derivatives using molinspiration analysis
Compound code Structure Mol. Wt (g/mol) HA HD Log P nrotb n violations
BT1 387.84 6 1 3.48 6 0
BT2 422.28 6 1 4.15 6 0
BT3 403.83 2 7 3.42 6 0
BT4 401.86 1 6 3.92 6 0
BT5 432.83 1 9 3.42 7 0
Standard (sorafenib) 414.81 3 7 4.03 5 0
Mol.wt: Molecular weight, HA: Hydrogen bond acceptors, HD: Hydrogen bond donors, nrotb: Number of rotatable bonds
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DISCUSSION
Using ACD Lab ChemSketch ver. 12.0, we have drawn five benzoxazole 
substituted azetidinone derivatives and found their molecular 
properties such as parachor, molar refractivity, surface tension, molar 
volume, polarizability, and refractive index. All these properties reveal a 
relationship between structural properties of chemical compounds and 
the biological activities. The Lipinski rule and its violation are verified 
in molinspiration cheminformatics as mentioned in Table 3. Lipinski 
rule states that the molecular weight should not exceed 500 Da, not 
more than 10 hydrogen bond acceptors and 5 hydrogen bond donors. 
The compounds that violated this rule are eliminated from further 
proceedings as they are unfit for docking studies. The Lipinski rule plays 
major role in pharmacokinetic properties like absorption, distribution, 
metabolism and elimination. The rule of five and drug likeness score 
of these five derivatives were found to possess good physio-chemical 
properties and is expected to be orally bioavailable. The biological 
activity of derivatives was predicted by PASS online software and 
benzoxazole bearing azetidinone derivatives were found to possess 
good anticancer activity (Pa more than 0.7) as shown in Table 1. The 
pharmacokinetic properties were predicted through Swiss ADME 
software. It showed that all the derivatives exhibit high gastro intestinal 
absorption and are non BBB premiant together with zero alert for PAINS. 
The molecular docking analysis of the selected derivatives with the 
receptor VEGFR-2 (4DBN) was evaluated. Schematic 3D representation 
of derivatives with receptor VEGFR-2 (4DBN) was obtained and shown 
in Fig. 4. The docking score of derivatives and the standard (sorafenib) 
with 4DBN is given in Table 5. Various hydrogen bond interactions were 
shown with Ser 535 for derivative BT1, Val 599 for derivative BT2, 
Phe 594 for derivative BT3, Asp 593 for derivative BT4, and Phe 582  for 
derivative BT5. Hence, all these five derivatives are expected to have 
good in vivo and in vitro anti-cancer activity.
CONCLUSION
The present study scientifically revealed the in silico design, ADME 
prediction, and docking studies to predict anticancer activity. We have 
selected five benzoxazole substituted azetidinone derivatives and all the 
compounds showed good molecular properties. Based on the analysis 
of Lipinski rule of five, all the derivatives passed the rule of five and 
therefor these compounds were further preceded to pharmacokinetic 
and docking studies. PASS online predicted anti-cancer activity for those 
derivatives. Swiss ADME studies resulted with all the five derivatives to 
be orally bioavailable and they do not cross BBB. From docking scores, 
we can conclude that the designed benzoxazole substituted azetidinone 
derivatives are found to have good interaction in binding pocket of 
target 4DBN, derivatives possess good anticancer activity with high 
binding affinity. So these compounds are expected to possess good anti-
cancer property with minimal side effects.
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Fig. 4: Docked images of derivatives and standard (sorafenib) 
with protein 4 DBN (ligand-binding domain of vascular 
endothelial growth factor 2. Purple color wires - Structural 
alignment of protein VEGFR-2 (4DBN); Yellow color dotted lines - 
Various amino acid interactions
